Science 37 Holdings, Inc (SNCE): Price and Financial Metrics

Science 37 Holdings, Inc (SNCE): $3.06

0.06 (+2.00%)

POWR Rating

Component Grades













SNCE Stock Price Chart Interactive Chart >

Price chart for SNCE

SNCE Price/Volume Stats

Current price $3.06 52-week high $15.10
Prev. close $3.00 52-week low $2.79
Day low $3.00 Volume 629,400
Day high $3.34 Avg. volume 215,845
50-day MA $4.50 Dividend yield N/A
200-day MA $8.72 Market Cap 354.95M

Science 37 Holdings, Inc (SNCE) Company Bio

Science 37 Holdings, Inc. engages in enabling universal access for clinical research to accelerate the development of treatments for patients and providers. The company develops decentralized clinical trials (DCT) technology platform that enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, as well as sponsors?to power workflows, centralize evidence generation, and harmonize data. It also offers Science 37 Metasite that provides networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating decentralized clinical trials. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, medical device, and biotech companies. The company was formerly known as Science 37, Inc. and changed its name to Science 37 Holdings, Inc. in October 2021. Science 37 Holdings, Inc. was founded in 2014 and is based in Culver City, California.

SNCE Latest News Stream

Event/Time News Detail
Loading, please wait...

SNCE Latest Social Stream

Loading social stream, please wait...

View Full SNCE Social Stream

Latest SNCE News From Around the Web

Below are the latest news stories about Science 37 Holdings Inc that investors may wish to consider to help them evaluate SNCE as an investment opportunity.

Science 37®’s Operating System Receives ISO Certification for Information Security Management

ISO 27001 certification and ISO 27701:2019 extension demonstrate Science 37’s commitment to quality, cybersecurity and privacy managementRESEARCH TRIANGLE PARK, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced its Operating System has earned ISO 27001 certification for cybersecurity management as well as the ISO 27701:2019 privacy management certification extension. These two certifications demonstrate Sc

Yahoo | February 24, 2022

Science 37® to Present at the Cowen 42nd Annual Health Care Conference

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Cowen 42nd Annual Health Care Conference. Science 37’s management is scheduled to present on Monday, March 7, 2022, at 1:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the company’s website at

Yahoo | February 23, 2022

Science 37®’s Community Provider Network Grows Sixfold, Reaching Nearly 28 Million Patients

Since January 2021, Science 37’s community provider network has added nearly 35,000 physician-providers to enable agile clinical trial execution.RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ bolstered its centralized network of community providers by six times during the past year, contracting with more than 800 healthcare organizations and gaining access to nearly 28 million patients worldwide

Yahoo | February 17, 2022

Science 37® and physIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices

Collaboration will yield objective, predictive, and real-time digital measures—supplementing clinical trial digital endpoints collected from biosensorsRESEARCH TRIANGLE PARK, N.C. and CHICAGO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and physIQ Inc, a leader in digital medicine, today announced a collaboration to help research sponsors use remote biosensors and machine learning to build more robust data sets. This wil

Yahoo | February 3, 2022

Could The Science 37 Holdings, Inc. (NASDAQ:SNCE) Ownership Structure Tell Us Something Useful?

Every investor in Science 37 Holdings, Inc. ( NASDAQ:SNCE ) should be aware of the most powerful shareholder groups...

Yahoo | January 24, 2022

Read More 'SNCE' Stories Here

SNCE Price Returns

1-mo -32.15%
3-mo -64.00%
6-mo -75.60%
1-year -69.79%
3-year N/A
5-year N/A
YTD -75.46%
2021 16.87%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5457 seconds.